Catalyst Wire Dossier Catalyst Wire Dossier

LAD106

· Almirall, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAD106, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LAD106 in Healthy Adult Participants [Phase 1]

See pricing